Week 2 Endocrine Flashcards
A1C reduction with glucose
What is the gold standard?
Insulin
reduces A1C by about 2.5
Everything else about 1.5
What drugs to use when compelling need to minimize hypoglycemia? (4)
DPP4
GLP1
SGLT2
TZD
Thiazolidinediones (2)*
Rosiglitazone (Avandia)
Pioglitazone (Actos)
Beta-Adrenergic Antagonists
MOA
Common agents
AE
Acts by decreasing symptoms of adrenergic stimulation caused by T4 concentrations
Inhibits peripheral conversion of T4 to T3
Propanolol (non selective BB)
Decreased BP, bradycardia, cardiac arrest
CHF, Asthma
Insulin Preparations
Rapid
Short
Intermediate
Long
Biguanides Old Contraindications*
Male Creatinine >/- 1.5mg/dL
Female Creatinine >/- 1.4mg/dL
What drug?
Direct acting (categorized based on duration after injection)
Major SE: Hypoglycemia
Insulin
Causes/Diagnoses of Hypothyroidism (3)
T4 concentrations
TSH concentrations
Hashimoto’s thyroiditis
Surgery
Meds (Lithium, RAI, Amiodarone)
Decreased total and free T4
Elevated TSH
What insulin cannot be mixed with others?*
Long Acting*
Basal Insulin
Adults secrete about __ unit of insulin per ___ regardless of food intake
Secreted in small amounts throughout the day 50%
1 unit per hour
DPP-4 Inhibitors
Adverse Effects
Well tolerated
Pancreatitis (rare)
Heart disease?
What drug?
Activates PPAR (steroid hormon) -> insulin sensitivity
Major SE: Peripheral edema, heart failure, bone loss, weight gain
Thiazolidinediones
Thioureas*
AE(3)
Rash
Fluid Retention
Decreased WBC** reverses on discontinuation if caught early
Types of Therapy for Hyperthyroidism (3)
Surgery
Meds
Radioactive iodine
GLP-1 Agonists*
What is it?
Recombinant peptide that shares 53% of amino acid sequence w human GLP-1
SGLT 2 Inhibitors
Administration
Oral daily dosing
Dose must be adjusted for renal dysfunction
Canagliflozin (Invokana)
Dosing Admin Renal Dose Adjustment Cost Patient Assistance
100-300mg daily Before first meal of the day Yes 350$ for 30 tablets Available
DPP-4 Inhibitors CV Safety
Overall they were neutral
Dapagliflozin (Farxiga)
Dosing Admin Renal Dose Adjustments Cost Patient Assistance
5-10mg daily In the morning with or without food Yes $350 for 30 tablets Available
Oral Combination Products a lot are combined with what drug?
Metformin
ie) Pioglitazone + Metformin, Glyburide + Metformin, etc
Thiazolidediones
AE (2)
____ Risk
Pioglitazone recommended against use if you have
Hepatotoxicity, Edema
Fracture (reduces osteoblastic activity and increases urinary calcium excretion)
Bladder Ca or hx
Hypoglycemia Picture of Sx
What do you do?
Shaky Fast Heartbeat Sweating Dizzy Anxious Hungry Blurry Vision Weakness of Fatigue Headache Irritable
Check -> Tx -> Check
Thyroid Hormones effect (2)
Growth and Development
Maintain metabolic stability
Short Acting Insulin (1)
Regular Humulin R
Biguanides New Contraindications*
GFR <30 = Contraindicated
GFR 30-45 = Do not start
GFR dips < 45 = Re-evaluate vs cut dose in half
GFR 30-60 with iodinated contrast = hold for 48 hrs
Adverse Effects of Insulin* (4)
Hypoglycemia
Insulin Allergy
Immune Insulin Resistance
Lipohypertrophy (rotate injection sites)
SGLT -2 CV Safety*
Significant CV reduction of residual CV risk!
GLP-1 Agonists (4)*
Exenatide (Byetta)
Liraglutide (Victoza)
Albiglutide (Tanzeum)
Duglaglutide (Trulicity)
Rapid Acting Insulin (3)
Insulin Lispro (Humalog) Insulin Aspart (Novalog) Insulin Glulisine (Aventis)
Levothyroxine*
Considered a “____”
Produces physiologic levels of?
Onset
Prodrug
T4 and T3
2-3 wks
What drugs to use when ASCVD predominates
1) SGLT2i*
2) GLP 1
Bolus Insulin
Also called
Larger amounts secreted in response to food to
In response to food 50%
Premeal, mealtime, prandial, nutritional insulin
Decrease postprandial hyperglycemia
Duration of action of Insulin is ______ in pts with (2) failure
Prolonged
Hepatic and Renal
Intermediate Acting Insulin
Onset Peak Duration \_\_\_ used for \_\_\_\_ IV use Usually administered Appearance*
2-4 hr 4-8 hr 8-12 hr NOT for emergency 1-2 times/day CLOUDY
Glucagon
Secreted by a cells
Increases hepatic glucose output -> increases blood glucose concentration
Thioureas*
MOA
Inhibits iodination of tyrosine
Coupling of iodotryrosines
PTU also inhibits peripheral conversion of T4 to T3
DOES NOT effect release of preformed T4 and T3
Glipizide (2)*
Duration
Active Metabolite
Elimination
Glucotrol, Glucotrol XL
12-16 hrs
Inactive
90% Hepatic
GLP 1 Agonists*
AE (3)
N/V
HA
Pancreatitis
Storage of Insulin*
Refrigerate if not in use
Room Temperature if in use/limit to 28 days
Away from direct heat or light
Check for clumps, frosting, failure to stay in suspension when mixed
Never use cloudy or discolored insulin except for NPH
Meglitinides Potential Advantages
_____ onset and ____ duration of action
May be used in pts with ____ insufficiency
May be useful in pts who ___ meals
AE (2)
Rapid, short
Renal
Skip
Hypoglycemia
Weight Gain
Diabetes Mellitus
A syndrome that develops when insulin secretion or activity are not sufficient to maintain blood glucose levels
Intermediate Acting Insulin (2)
NPH Humulin N
NPH Novolin N
*Insulin Dose based on:
Type 2:
Type 1:
Observe for
Total Body Weight
0.2 u/kg/day
Depends
Trends in hypoglycemia and hyperglycemia
Comparison of Common Agents
Equvalent Glucocorticoid dose, Mineralcorticoid potency
1) Hydrocortisone
2) Cortisone
3) Prednisone
4) Methylprednisolone
5) Dexamethasone
1) 20, +2
2) 25, +2
3) 5, +1
4) 4, +1
5) 0.75, 0
Levothyroxine Adverse Effects (4)*
HF
Angina (painful constriction of tightness)
MI
Hyperthyroidism
Short Acting Insulin
Onset Peak Duration Administered May be given Appearance
30 min 2-3 hr 4-6 hr 30-45 min before a meal* IV Clear
Intermediate/Long Uses (2)
Basal insulin needs
Not to cover meals
Thioureas (2)*
Propylthiouracil (PTU)
Methimazole (Tapazole)
DM Type II
NIDDM
- results from insulin secretory defect and insulin resistance
RELATIVE lack of insulin
Thyroid Hormone Synthesis and Release
Iodine + Tyrosine
Organification into T1 and T2
Coupling into T3 and T4
Secretion of T3 and T4 into circulation
T4 is solely secreted from thyroid gland